Back to top

Image: Bigstock

Is Nu Skin Enterprises (NUS) a Good Value Investor Stock?

Read MoreHide Full Article

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value?

One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process. Let’s put Nu Skin Enterprises, Inc. (NUS - Free Report) stock into this equation and find out if it is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks:

PE Ratio

A key metric that value investors always look at is the Price to Earnings Ratio, or PE for short. This shows us how much investors are willing to pay for each dollar of earnings in a given stock, and is easily one of the most popular financial ratios in the world. The best use of the PE ratio is to compare the stock’s current PE ratio with: a) where this ratio has been in the past; b) how it compares to the average for the industry/sector; and c) how it compares to the market as a whole.

On this front, Nu Skin Enterprises has a trailing twelve months PE ratio of 18.25, as you can see in the chart below:


 
This level actually compares favorably with the market at large, as the PE for the S&P 500 stands at about 23.66. If we focus on the long-term PE trend, Nu Skin Enterprises’ current PE level puts it below its midpoint over the past five years. Moreover, the current level is fairly below the highs for this stock, suggesting it might be a good entry point.


 
However, the stock’s PE also compares unfavorably with the Zacks Consumer Staples sector’s trailing twelve months PE ratio, which stands at 22.76. At the very least, this indicates that the stock is slightly undervalued right now, compared to its peers.


 
We should also point out that Nu Skin Enterprises has a forward PE ratio (price relative to this year’s earnings) of just 16.91, so it is fair to say that a slightly more value-oriented path may be ahead for Nu Skin Enterprises’ stock in the near term too.

P/S Ratio

Another key metric to note is the Price/Sales ratio. This approach compares a given stock’s price to its total sales, where a lower reading is generally considered better. Some people like this metric more than other value-focused ones because it looks at sales, something that is far harder to manipulate with accounting tricks than earnings.

Right now, Nu Skin Enterprises has a P/S ratio of about 1.1. This is substantially lower than the S&P 500 average, which comes in at 4.22 right now. Also, as we can see in the chart below, this is somewhat below the highs for this stock in particular over the past few years.

Broad Value Outlook

In aggregate, Nu Skin Enterprises currently has a Value Score of B, putting it into the top 40% of all stocks we cover from this look. This makes Nu Skin Enterprises a solid choice for value investors, and some of its other key metrics make this pretty clear too.

For example, the PEG ratio for Nu Skin Enterprises is just 3.02, a level that is lower than the industry average of 3.40. The PEG ratio is a modified PE ratio that takes into account the stock’s earnings growth rate. Additionally, its P/CF ratio (another great indicator of value) comes in at 11.30, which is better than the industry average of 18.93. Clearly, NUS is a solid choice on the value front from multiple angles.

What About the Stock Overall?

Though Nu Skin Enterprises might be a good choice for value investors, there are plenty of other factors to consider before investing in this name. In particular, it is worth noting that the company has a Growth Score of B and Momentum Score of B. This gives NUS a Zacks VGM score — or its overarching fundamental grade — of A. (You can read more about the Zacks Style Scores here >>)

Meanwhile, the company’s recent earnings estimates have been encouraging. The current year has seen five upward revisions in the past sixty days compared to no downward revision, while the full year 2021 estimate has also seen five upward revision compared to no downward revision in the same time period.

This has had a noticeable impact on the consensus estimate, as the current year consensus estimate increased 23.9% in the past two months, whereas the full year 2021 estimate increased 14.6% in the past two months. You can see the consensus estimate trend and recent price action for the stock in the chart below:

Nu Skin Enterprises, Inc. Price and Consensus

Notably, the stock with favorable estimate trends has a Zacks Rank #1 (Strong Buy), which is why we are looking for outperformance from the company in the near term.

Bottom Line

Nu Skin Enterprises is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front. Furthermore, the company sports a Zacks Rank #1, which indicates that the broader factors are favorable for the company.

So, value investors might want to delve deeper in this stock as it appears to be a compelling pick.

The Hottest Tech Mega-Trend of All

Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>


Zacks' 7 Best Strong Buy Stocks (New Research Report)


Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.


Click Here, It's Really Free

Published in